VITORA: Clinical Study to Evaluate the Effect of KB109 on the Gut Microbiome in Subjects Whose Gastrointestinal Tracts Are Colonized With Multiple Drug-resistant Organisms

NCT03944369 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

3

Enrollment

INDUSTRY

Sponsor class

Stopped COVID-19 pandemic

Conditions

Vancomycin-Resistant Enterococcus, Extended-Spectrum Beta Lactamase-Producing Enterobacteriaceae, or Carbapenem-Resistant Enterobacteriaceae Colonized Subjects

Interventions

OTHER: KB109
OTHER: No intervention

Sponsor

Kaleido Biosciences